JNJ's Crucell halts supply of 2.36 mln flu vaccines to Italy
PARIS Oct 17 (Reuters) - Crucell, the vaccines unit of U.S. drugmaker Johnson & Johnson , has suspended a delivery of 2.36 million seasonal flu vaccine doses to Italy after it found problems with two lots of it, the Italian health ministry said on Wednesday.
The ministry said in a statement that the Netherlands-based vaccine maker halted the planned supply of its Inflexal V vaccine after two lots out of 32 failed quality checks.
Crucell was not immediately available for comment.
Italy's flu vaccination campaign will start as planned because health authorities will fill in the shortfall by purchasing more doses from other manufacturers, the statement said.
Italy uses between 10 and 12 million doses of flu vaccines every year, the health ministry said.
- More troops deployed in Ferguson to guard against fresh riots |
- Merkel hits diplomatic dead-end with Putin
- Jewish-nation bill frays Israel's delicate social fabric
- Ukraine reports new arrivals of Russian supplies for eastern rebels |
- Gunshots echo as violence returns to Ferguson, protests across U.S.
We are living longer but not creating financial plans to keep pace. Advisers give tips on how to make sure you don’t outlive your money. Video